Tirzepatide, the recently approved medication, is creating considerable interest within the healthcare community. It operates differently from existing diabetes medications, targeting two receptors involved in sugar regulation and appetite . Initial research have demonstrated impressive efficacy in reducing blood sugar in individuals with diabetes